TickerFacts.

A business in context

MRNA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-14 · 0001682852-26-000187

  2. 4 · Ownership change

    Report date 2026-10-05 · 0001682852-26-000185

  3. 8-K · Current report

    Report date 2026-09-30 · 0001193125-26-408289 · Items 5.02,7.01,9.01

  4. 4 · Ownership change

    Report date 2026-09-14 · 0001682852-26-000176

  5. 4 · Ownership change

    Report date 2026-09-10 · 0001682852-26-000174

  6. 4 · Ownership change

    Report date 2026-09-04 · 0001682852-26-000172

  7. 4 · Ownership change

    Report date 2026-09-04 · 0001682852-26-000169

  8. 4 · Ownership change

    Report date 2026-09-01 · 0001682852-26-000167

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001682852-26-000165

  10. 8-K · Current report

    Report date 2026-08-27 · 0001193125-26-378505 · Items 1.01,2.03,3.02,8.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001682852-26-000150

  12. 8-K · Current report

    Report date 2026-07-31 · 0001682852-26-000147 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-07-06 · 0001682852-26-000134 · Items 5.02,7.01,9.01

  14. 8-K · Current report

    Report date 2026-05-06 · 0001682852-26-000101 · Items 5.03,5.07,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001682852-26-000060

  16. 8-K · Current report

    Report date 2026-05-01 · 0001682852-26-000057 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-05-06 · 0001308179-26-000081

  18. 8-K · Current report

    Report date 2026-03-03 · 0001682852-26-000047 · Items 1.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001682852-26-000033

  20. 8-K · Current report

    Report date 2026-02-13 · 0001682852-26-000015 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-03 · 0001682852-26-000012 · Items 7.01,8.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001682852-26-000007 · Items 2.02,7.01,9.01

  23. 8-K · Current report

    Report date 2026-01-05 · 0001682852-26-000003 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2025-11-19 · 0001628280-25-053816 · Items 1.01,2.03,9.01

  25. 8-K · Current report

    Report date 2025-11-20 · 0001628280-25-053318 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-11-12 · 0001628280-25-052055 · Items 5.07

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001682852-25-000075

  28. 8-K · Current report

    Report date 2025-11-06 · 0001682852-25-000073 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-11-12 · 0001682852-25-000062

  30. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001682852-25-000044

  31. 8-K · Current report

    Report date 2025-08-01 · 0001682852-25-000041 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-04-30 · 0001682852-25-000036 · Items 5.07

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001682852-25-000034

  34. 8-K · Current report

    Report date 2025-05-01 · 0001682852-25-000031 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-04-30 · 0001308179-25-000082

  36. 10-K · Annual report

    Report date 2024-12-31 · 0001682852-25-000022

  37. 8-K · Current report

    Report date 2025-02-14 · 0001682852-25-000006 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-01-13 · 0001682852-25-000002 · Items 2.02,7.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001682852-24-000060

  40. 8-K · Current report

    Report date 2024-11-07 · 0001682852-24-000057 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 10 transaction rows10SGrant / award: 5 transaction rows5AExercise / conversion: 42 transaction rows42MTax / exercise payment: 12 transaction rows12FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

69 matching transaction rows. Showing 51 to 69.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock187044.058.79
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock147473.056.21
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock499246.019.15
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock39891.058.12
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
370853.00.0
2026-08-05
2026-08-07
Bancel Stephane
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
128393.00.0
2026-07-15
2026-07-16
Hoge Stephen
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock37226.019.15
2026-07-15
2026-07-16
Hoge Stephen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock53336.067.6
2026-07-15
2026-07-16
Hoge Stephen
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock16110.019.15
2026-07-15
2026-07-16
Hoge Stephen
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
37226.00.0
2026-07-15
2026-07-16
Hoge Stephen
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
16110.00.0
2026-07-08
2026-07-10
McDonnell Michael R.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
7415.00.0
2026-07-08
2026-07-10
McDonnell Michael R.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
5733.00.0
2026-07-08
2026-07-10
McDonnell Michael R.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
1618.00.0
2026-07-05
2026-07-07
Banque Soria EsterA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
18658.00.0
2026-07-05
2026-07-07
Banque Soria EsterA · Grant / award
Acquired
Restricted Stock Units
Derivative security
38364.00.0
2026-07-02
2026-07-06
Mock James MM · Exercise / conversion
Acquired
Common Stock1452.0n/a
2026-07-02
2026-07-06
Mock James MF · Tax / exercise payment
Disposed
Common Stock703.072.5
2026-07-02
2026-07-06
Mock James MM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
1452.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001682852Moderna, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300EI6OKH5K5Q2G38
GLEIF legal name
MODERNA, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-12-16T10:33:56Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Moderna · alias · wikidata
  • Moderna Therapeutics · alias · wikidata
  • Moderna Therapeutics, Inc. · alias · wikidata
  • Moderna Therapeutics, Inc. · former SEC name · 2016-08-24 to 2016-08-24
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.24B$3.48B
2023-12-31$6.85B$7.57B
2022-12-31$19.26B$22.17B
2021-12-31$18.47B$22.96B
2019-12-31$60.21M$79.35M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗